Aims
The MED-FED survey sought a more comprehensive understanding of the impact and possible adverse effects of various drugs upon eating disorder symptomatology and general mental health. The findings indicated that the perceived health benefits of substances like psychedelics and cannabis often rating more favourably than conventional prescription medications. The survey also identified nuanced differences in perceived drug efficacy across various eating disorder diagnoses.

Background
Few effective pharmacotherapies exist for eating disorders, and there is a limited understanding of how individuals with eating disorders experience prescription and non-prescription drug use. MED-FED is one of the most detailed accounts to date of contemporary prescription and non-prescription drug use in people with eating disorders. It highlights emerging patterns in patient-reported outcomes, offering valuable guidance for future research, clinical consideration, and potential development of more effective, patient-informed pharmacological treatments.